<?xml version="1.0" encoding="utf-8"?>
<items><story><date>17:31 03 January 2007 (UTC)</date><text>WASHINGTON Jan 3 Oculus Innovative Sciences
Inc., a maker of products to help prevent infection in chronic
and acute wounds, on Wednesday raised the number of shares for
its planned initial public offering to 3.5 million from 3.1
million. It also lowered the estimated price range to between $8 and
$10 per share from $12 to $14, according to an amended offering
document filed with the U.S. Securities and Exchange
Commission. The underwriters, led by Roth Capital Partners, will have
the option to buy more than 460,000 additional shares to cover
over-allotments. The Petaluma, California-based company said it has been
approved to list its stock on Nasdaq under the symbol "OCLS"
(OCLS.O).



</text><link>http://www.reuters.com/article/2007/01/03/oculus-ipo-idUSN0343883220070103</link><sectors><value><value>Regulatory News, </value><value>IPOs</value></value></sectors><title>oculus raises ipo size , lowers price range</title></story></items>